Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic parameters: how important are pharmacologically-induced changes?

R J Northcote1

  • 1Cardiology Department, Victoria Infirmary, Glasgow, UK.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hospital volume of throughput and periprocedural and medium-term adverse events after percutaneous coronary intervention: retrospective cohort study of all 17,417 procedures undertaken in Scotland, 1997-2003.

Heart (British Cardiac Society)·2006
Same author

Cardiac assessment of veteran endurance athletes: a 12 year follow up study.

British journal of sports medicine·1999
Same author

The effect of habitual sustained endurance exercise on cardiac structure and function.

European heart journal·1990
Same author

Silent myocardial ischaemia: characteristics and management.

International journal of cardiology·1990
Same author

Cardiac disease and exercise--a modern paradox.

The Journal of pathology·1989
Same author

Electrocardiographic findings in male veteran endurance athletes.

British heart journal·1989
Same journal

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Hypertension and kidney alterations in rat offspring from low protein pregnancies.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Comparison of the effects of indapamide and captopril on the development of spontaneous hypertension.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
See all related articles

Beta-blockers may not significantly reduce coronary disease in hypertensives due to adverse effects on lipid profiles. However, they can reduce endothelial damage and plaque formation by lowering blood flow velocity and catecholamines.

Area of Science:

  • Cardiovascular pharmacology
  • Lipid metabolism
  • Hypertension management

Background:

  • Beta-blockers are used for hypertension but their effect on coronary disease is debated.
  • Concerns exist regarding their impact on plasma lipoprotein profiles, specifically triglycerides and high-density lipoprotein levels.
  • Different types of beta-blockers exhibit varying effects on lipid profiles and clinical outcomes.

Purpose of the Study:

  • To investigate the impact of beta-blockers on coronary disease frequency in hypertensive patients.
  • To analyze the relationship between beta-blocker-induced changes in lipoprotein profiles and their efficacy in reducing coronary events.
  • To explore the mechanisms by which beta-blockers might influence atherosclerosis development.

Main Methods:

Related Experiment Videos

  • Review of existing literature on beta-blocker effects on lipid profiles (triglycerides, HDL).
  • Analysis of studies examining the correlation between beta-blocker use, lipid changes, and coronary disease incidence.
  • Examination of the physiological effects of beta-blockers on vascular endothelium, blood flow velocity, and catecholamine activity.

    • Main Results:

    • Non-selective beta-blockers significantly elevate triglycerides and reduce high-density lipoprotein levels.
    • Cardioselective beta-blockers show similar but less pronounced adverse effects on lipids.
    • Beta-blockers with intrinsic sympathomimetic activity have minimal impact on lipids but are less effective in reducing coronary mortality.
    • Animal studies indicate beta-blockers can reduce atherosclerosis despite lipid profile alterations.

    Conclusions:

    • The adverse effects of certain beta-blockers on lipid profiles may offset their benefits in reducing coronary disease frequency in hypertensives.
    • Beta-blockers' ability to reduce endothelial damage via decreased blood flow velocity and catecholamine activity is a potential mechanism for anti-atherosclerotic effects.
    • Further research is needed to fully elucidate the complex interplay between beta-blocker therapy, lipid metabolism, and cardiovascular outcomes in hypertensive patients.